🇺🇸 BIAsp 30 in United States

BIAsp 30 (BIAsp 30) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

BIAsp 30 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BIAsp 30 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for BIAsp 30 in United States?

Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.